<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575080</url>
  </required_header>
  <id_info>
    <org_study_id>R&amp;D-2011-2012-0.20</org_study_id>
    <nct_id>NCT01575080</nct_id>
  </id_info>
  <brief_title>Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design</brief_title>
  <official_title>Performance Evaluation of the Contour TS BGMS Using ISO/DIS 15197:2011 Section 8 Study Design and Performance Criteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ascensia Diabetes Care</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ascensia Diabetes Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if untrained subjects who have diabetes can operate
      the Blood Glucose Monitoring System (BGMS) and obtain acceptable glucose results.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</measure>
    <time_frame>1 hour</time_frame>
    <description>Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</measure>
    <time_frame>1 hour</time_frame>
    <description>Untrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</measure>
    <time_frame>1 hour</time_frame>
    <description>Untrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements</measure>
    <time_frame>1 hour</time_frame>
    <description>Subjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Intended Users of the Monitoring System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Contour TS Blood Glucose Monitoring System</intervention_name>
    <description>Untrained subjects with diabetes perform self Blood Glucose (BG) tests with capillary fingerstick blood and AST of the palm and forearm using the Contour TS Blood Glucose Monitoring System. All BG results are compared to a reference laboratory glucose method.</description>
    <arm_group_label>Intended Users of the Monitoring System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a diagnosis of diabetes

          -  Be 18 years of age or older

          -  Be able to speak, read and understand English and understand the Informed Consent
             document.

          -  Be willing to complete study procedures

        Exclusion Criteria:

          -  Pregnancy

          -  Infections or skin disorders at the puncture site (at the discretion of the site
             professional staff).

          -  Hemophilia, bleeding disorder, or clotting problems. Persons taking aspirin (81 mg or
             325 mg) daily or PlavixÂ® are not reason for exclusion.

          -  Physical (dexterity), visual, or neurological impairments that would make the person
             unable to perform testing with the BGM (at the discretion of the site professional
             staff).

          -  A condition, in the opinion of the Investigator, would put the subject at risk or
             influence the conduct of the study or interpretation of the results. The reason for
             exclusion will be documented by the professional staff.

          -  Previously participated in a blood glucose monitoring study using Contour TS system or
             use the Contour TS for personal use when monitoring blood glucose.

          -  Working for a competitive medical device company or having an immediate family member
             or someone who is not a family member but is living within the household of someone
             who works for such a company

          -  Working for a medical laboratory, hospital or other clinical setting that involves
             training on and clinical use of blood glucose monitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Simmons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ascensia Diabetes Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bayer HealthCare LLC, Diabetes Care</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46544</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2012</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <results_first_submitted>April 26, 2013</results_first_submitted>
  <results_first_submitted_qc>April 26, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 8, 2013</results_first_posted>
  <last_update_submitted>January 29, 2016</last_update_submitted>
  <last_update_submitted_qc>January 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intended Users of the Monitoring System</title>
          <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intended Users of the Monitoring System</title>
          <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" lower_limit="19" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
        <description>Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
        <time_frame>1 hour</time_frame>
        <population>102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System.</population>
        <group_list>
          <group group_id="O1">
            <title>Intended Users of the Monitoring System</title>
            <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
          <description>Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
          <population>102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System.</population>
          <units>Number of BG Test Results</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>BG test results</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
        <description>Untrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
        <time_frame>1 hour</time_frame>
        <population>102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System</population>
        <group_list>
          <group group_id="O1">
            <title>Intended Users of the Monitoring System</title>
            <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
          <description>Untrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
          <population>102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System</population>
          <units>Number of BG Test Results</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>BG test results</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
        <description>Untrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
        <time_frame>1 hour</time_frame>
        <population>102 untrained subjects tested one test strip lot using the Contour TS BG Monitoring System. One subject was unable to obtain sufficient sample volume to test. Another subject's meter displayed</population>
        <group_list>
          <group group_id="O1">
            <title>Intended Users of the Monitoring System</title>
            <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (&lt;100mg/dL) or Within +/- 15% (&gt;=100mg/dL) of Laboratory Glucose Method</title>
          <description>Untrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (&lt;100mg/dL YSI capillary plasma) or +/- 15% (&gt;=100mg/dL YSI capillary plasma).</description>
          <population>102 untrained subjects tested one test strip lot using the Contour TS BG Monitoring System. One subject was unable to obtain sufficient sample volume to test. Another subject's meter displayed</population>
          <units>Number of BG Test Results</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>BG test results</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements</title>
        <description>Subjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intended Users of the Monitoring System</title>
            <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements</title>
          <description>Subjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>I found it easy to do a blood test w this meter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Meter display (test result) is easy to read</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Easy to see and understand the test results</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I like the overall meter design</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Meter is easy to handle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Easy to handle the individual test strips</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Instructions (User Guide) easy to understand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Instructions clearly explain how to run a test</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Instructions clearly explain meter error message</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I found this meter easy to use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I found this meter intuitive</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I found this meter practical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intended Users of the Monitoring System</title>
          <description>Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>hypoglycemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Carmine Greene</name_or_title>
      <organization>Ascensia Diabetes Care</organization>
      <phone>574-257-3040</phone>
      <email>carmine.greene@ascensia.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

